Related Experiment Video
Updated: Mar 30, 2026
Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
Cell Death and Cancer Therapy: Don't Forget to Kill the Cancer Cell!
1Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. anthony_letai@dfci.harvard.edu.
Abstract:
In our current age of targeted therapies, there is understandably considerable attention paid to the specific molecular targets of pharmaceutical intervention. For a targeted drug to work, it must bind to a target selectively and impair its function. Monitoring biomarkers of the impaired target function can provide vital in vivo pharmacodynamic information. Moreover, genetic changes to the target are often the source of resistance to targeted agents. However, for the treatment of cancer, it is necessary that the therapy not only provide efficient binding and inhibition of the target, but also that this intervention reliably kills the cancer cell. In this CCR Focus section, four articles make the connection between therapies that target T-cell activation, autophagy, IAP proteins, and BCL-2 and the commitment of cancer cells to cell death. Before addressing those exciting classes of targeted therapies, however, an overview is provided to discuss cell death induced by what is arguably still the most successful set of drugs in the history of medical oncology, conventional chemotherapy. See all articles in this CCR Focus section, "Cell Death and Cancer Therapy."
Insights
Targeted cancer therapies aim to selectively inhibit molecular targets. This focus section explores how targeting T-cell activation, autophagy, IAP proteins, and BCL-2 promotes cancer cell death, building on conventional chemotherapy insights.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Targeted therapies are crucial in modern medicine, focusing on specific molecular targets.
- Drug efficacy relies on selective binding and impaired target function, monitored via biomarkers.
- Cancer treatment requires therapies that not only inhibit targets but also induce cancer cell death.
Purpose of the Study:
- To explore the connection between targeted therapies and cancer cell death.
- To provide an overview of cell death induced by conventional chemotherapy.
- To highlight novel targeted therapies impacting cancer cell fate.
Main Methods:
- Review of current literature on targeted therapies and cell death mechanisms.
- Analysis of therapies targeting T-cell activation, autophagy, IAP proteins, and BCL-2.
- Discussion of conventional chemotherapy's role in inducing cell death.
Main Results:
- Several targeted therapies are linked to cancer cell death.
- Understanding resistance mechanisms, often due to genetic target changes, is vital.
- Conventional chemotherapy remains a highly successful treatment modality.
Conclusions:
- Targeted therapies must effectively induce cancer cell death for successful treatment.
- Investigating novel targets like T-cell activation, autophagy, IAP, and BCL-2 is critical.
- Integrating knowledge of conventional chemotherapy with targeted approaches enhances cancer therapy strategies.
More Related Videos
10:03Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
01:31The Intrinsic Apoptotic Pathway